{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T01:35:54Z","timestamp":1750383354886},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1245\/s10434-020-09408-3","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T18:32:36Z","timestamp":1606242756000},"page":"2763-2764","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ASO Author Reflections: How Should Adrenal Incidentalomas be Managed in the Current Era?"],"prefix":"10.1245","volume":"28","author":[{"given":"Eren","family":"Berber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"9408_CR1","doi-asserted-by":"publisher","unstructured":"Akbulut S, Erten O, Kahramangil B, et al. A critical analysis of CT wash-out in lipid-poor adrenal incidentalomas. Ann Surg Oncol. 2020. https:\/\/doi.org\/10.1245\/s10434-020-09329-1.","DOI":"10.1245\/s10434-020-09329-1"},{"key":"9408_CR2","doi-asserted-by":"publisher","unstructured":"Kahramangil B, Kose E, Remer EM, et al. A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients. Ann Surg. Epub 11 Jun 2020. https:\/\/doi.org\/10.1097\/sla.0000000000004048.","DOI":"10.1097\/sla.0000000000004048"},{"key":"9408_CR3","unstructured":"NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). NIH Consens State Sci Statements. 2002;19(2):1\u201325."},{"issue":"1","key":"9408_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.15.S1.1","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas. Endocr Pract. 2009;15(1):1\u201320.","journal-title":"Endocr Pract."},{"issue":"4","key":"9408_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.surg.2014.06.042","volume":"156","author":"O Birsen","year":"2014","unstructured":"Birsen O, Akyuz M, Dural C, et al. A new risk stratification algorithm for the management of patients with adrenal incidentalomas. Surgery. 2014;156(4):959\u2013965.","journal-title":"Surgery."},{"issue":"9","key":"9408_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","volume":"8","author":"I Bancos","year":"2020","unstructured":"Bancos I, Taylor AE, Chortis V, et al. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.\u00a0Lancet Diabetes Endocrinol. 2020;8(9):773\u2013781. https:\/\/doi.org\/10.1016\/s2213-8587(20)30218-7.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"9408_CR7","doi-asserted-by":"crossref","unstructured":"Yu H, Parakh A, Blake M, et al. Texture analysis as a radiomic marker for differentiating benign from malignant adrenal tumors. J Comput Assist Tomogr. 2020;44:766\u2013771.","DOI":"10.1097\/RCT.0000000000001051"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09408-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T17:21:07Z","timestamp":1618334467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09408-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["9408"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09408-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Unrelated to this work, Eren Berber has consulting agreements with Ethicon, Medtronic, Aesculap and Integra, and has received honoraria for these consulting activities that were unrelated to adrenal surgery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}